tuberculosis infection
Showing 1 - 25 of 28
Tuberculosis Infection Trial in Saint Petersburg (TB/Flu-05E vaccine, Placebo)
Active, not recruiting
- Tuberculosis Infection
- TB/Flu-05E vaccine
- Placebo
-
Saint Petersburg, Russian FederationSmorodintsev Research Institute of Influenza
Jul 11, 2023
Tuberculosis, Pulmonary, Tuberculosis Infection Trial in Worldwide (Rifabutin, Delamanid, Bedaquiline)
Not yet recruiting
- Tuberculosis, Pulmonary
- Tuberculosis Infection
- Rifabutin
- +7 more
-
Denver, Colorado
- +14 more
Mar 2, 2023
Latent Tuberculosis Infection in Health-care Workers and
Recruiting
- Tuberculosis
- +4 more
- Prevalence of Latent Tuberculosis Infection
-
Roma, ItalyUOSD Allergologia e Immunologia Clinica, Fondazione Policlinico
Mar 1, 2023
Tuberculosis Infection, HIV Trial in Zomba (CAD4TB, FujiLAM)
Completed
- Tuberculosis Infection
- HIV Infections
- CAD4TB
- FujiLAM
-
Zomba, MalawiZomba Central Hospital
Jan 23, 2023
AIDS, Histoplasmosis AIDS, Tuberculosis Infection Trial in Mexico City (Histoplasma Urine Antigen Lateral Flow Antigen test,
Not yet recruiting
- Acquired Immunodeficiency Syndrome
- +3 more
- Histoplasma Urine Antigen Lateral Flow Antigen test
- +2 more
-
Mexico City, Mexico
- +3 more
Jan 12, 2023
HIV Seropositivity, Pregnancy, Tuberculosis Infection Trial in Tembisa (Rifapentine, Isoniazid)
Not yet recruiting
- HIV Seropositivity
- +2 more
-
Tembisa, Gauteng, South AfricaThe Aurum Institute: Tembisa Clinical Research Centre
Dec 9, 2022
Tuberculosis, Tuberculosis, Pulmonary, Tuberculosis Infection Trial (Training for traditional and modern care providers)
Not yet recruiting
- Tuberculosis
- +2 more
- Training for traditional and modern care providers
- (no location specified)
Jul 21, 2022
Tuberculosis Infection, Tuberculosis Trial (BCG vaccine, Oral Chemoprophylaxis)
Not yet recruiting
- Tuberculosis Infection
- Tuberculosis
- BCG vaccine
- Oral Chemoprophylaxis
- (no location specified)
Jul 4, 2022
Tuberculosis Infection Trial in Zurich (Nivaquine ® (Chloroquine))
Recruiting
- Tuberculosis Infection
- Nivaquine ® (Chloroquine)
-
Zurich, SwitzerlandClinical Trial Center
Jun 28, 2022
Tuberculosis Infection, Isoniazid Adverse Reaction Trial (Low-dose isoniazid, Standard dose of isoniazid, High-dose isoniazid)
Not yet recruiting
- Tuberculosis Infection
- Isoniazid Adverse Reaction
- Low-dose isoniazid
- +2 more
- (no location specified)
Jun 7, 2022
Community TB Services Pre and Post the CHIP-TB Trial
Recruiting
- Tuberculosis Infection
- Tuberculosis Prevention
-
Addis Ababa, Ethiopia
- +1 more
Jun 8, 2022
Tuberculosis, HIV Coinfection, Tuberculosis Infection Trial (patient-centered TB preventive therapy, TB preventive therapy
Not yet recruiting
- Tuberculosis
- +2 more
- patient-centered TB preventive therapy
- TB preventive therapy adherence support
- (no location specified)
Apr 21, 2022
Collision of Three Global Pandemics: Effect of Tuberculosis and
Not yet recruiting
- COVID-19
- +3 more
- Covid-19, TB and HIV diagnosis
- (no location specified)
Mar 2, 2022
Tuberculosis Infection Trial in United States (BCG (Tokyo 172) vaccine, Placebo)
Recruiting
- Tuberculosis Infection
- BCG (Tokyo 172) vaccine
- Placebo
-
Birmingham, Alabama
- +5 more
Dec 16, 2021
Pediatric HIV Infection, Tuberculosis Infection Trial (rifampicin)
Not yet recruiting
- Pediatric HIV Infection
- Tuberculosis Infection
- (no location specified)
Sep 26, 2021
Development of Automated Molecular Diagnostic Platform for
Enrolling by invitation
- Tuberculosis Infection
-
Seoul, Songpa, Korea, Republic ofAsan Medical Center, University of Ulsan College of Medicine
Jul 25, 2021
COPD Co-infection With Tuberculosis on Th17 Cell Differentiation
Completed
- Tuberculosis Infection
- Chronic Obstructive Pulmonary Disease
- No intervention
-
Beijing, Beijing, ChinaPeking University Third Hospital
Jul 14, 2021
Tuberculosis, Pulmonary, Tuberculosis, MDR, Tuberculosis Infection Trial in Tbilisi, Soweto, Klerksdorp (Control group, ASA
Recruiting
- Tuberculosis, Pulmonary
- +2 more
- Control group
- +3 more
-
Tbilisi, Georgia
- +2 more
Apr 6, 2021
HIV, Tuberculosis Infection, Hepatitis C Trial (ART Therapy)
Active, not recruiting
- HIV Infections
- +3 more
- ART Therapy
- (no location specified)
Dec 16, 2020
Tuberculosis Infection Trial in Terrassa (TB infection-screening benefiting group)
Unknown status
- Tuberculosis Infection
- TB infection-screening benefiting group
-
Terrassa, Barcelona, SpainHospital Universitari Mutua Terrassa
Jul 17, 2020
Tuberculosis, Tuberculosis Infection Trial in Lyon (Multiple blood samples, Single blood sample)
Recruiting
- Tuberculosis
- Tuberculosis Infection
- Multiple blood samples
- Single blood sample
-
Lyon, FranceService des Maladies Infectieuses - Hôpital de la Croix Rousse -
Feb 12, 2020
/or Prognostic Markers of IRIS in TB-HIV Co-infected Patients
Unknown status
- HIV Infection
- Tuberculosis Infection
- Detection of molecular Biomarkers
-
Phnom Penh, CambodiaInstitut Pasteur du Cambodge
Jan 6, 2020
Evaluation of Immune Cell Markers in Diagnosis of Tuberculosis
Unknown status
- Tuberculosis Infection
- TB-antigen responsive T cell markers
-
Shanghai, Shanghai, ChinaShanghai Pulmonary Hospital
Oct 31, 2019
Tuberculosis Infection Trial in South Africa, Tanzania (H56:IC31, Placebo)
Withdrawn
- Tuberculosis Infection
- H56:IC31
- Placebo
-
Klerksdorp, South Africa
- +3 more
Apr 6, 2018
Diagnostics for Paediatric Tuberculosis by Blood Culture
Completed
- Tuberculosis Infection
-
Hanoi, VietnamNational Hospital of Pediatrics
Nov 13, 2016